| ［1］ AlvaradoLuna G, MoralesEspinosa D. Treatment for small cell lung cancer, where are we now?—a review［J］. Transl Lung Cancer Res, 2016, 5(1): 26-38. DOI: 10.3978/j.issn.22186751.2016.01.13.
［2］ Califano R, Abidin AZ, Peck R, et al. Management of small cell lung cancer: recent developments for optimal care［J］. Drugs, 2012, 72(4): 471-490. DOI: 10.2165/11597640-000000000-00000.
［3］ Koinis F, Kotsakis A, Georgoulias V. Small cell lung cancer (SCLC): no treatment advances in recent years［J］. Transl Lung Cancer Res, 2016, 5(1): 39-50. DOI: 10.3978/j.issn.22186751.2016.01.03.
［4］ Sgambato A, Casaluce F, Maione P, et al. Medical treatment of small cell lung cancer: state of the art and new development［J］. Expert Opin Pharmacother, 2013, 14(15): 2019-2031. DOI: 10.1517/14656566.2013.823401.
［5］ Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive smallcell lung cancer［J］. N Engl J Med, 2002, 346(2): 85-91.
［6］ Hanna N, Bunn PA, Langer C, et al. Randomized phase Ⅲ trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensivestage disease smallcell lung cancer［J］. J Clin Oncol, 2006, 24(13): 2038-2043. DOI: 10.1200/JCO.2005.04.8595.
［7］ Schmittel A, Sebastian M, Fischer Von Weikersthal L, et al. A German multicenter, randomized phase Ⅲ trial comparing irinotecancarboplatin with etoposidecarboplatin as firstline therapy for extensivedisease smallcell lung cancer［J］. Ann Oncol, 2011, 22(8): 17981804. DOI: 10.1093/annonc/mdq652.
［8］ Slotman BJ, Van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage smallcell lung cancer: a phase 3 randomised controlled trial［J］. Lancet, 2015, 385(9962): 36-42. DOI: 10.1016/S0140-6736(14)61085-0.
［9］ Rossi A, Sacco PC, Sgambato A, et al. Optimal drugs for secondline treatment of patients with smallcell lung cancer［J］. Expert Opin Pharmacother, 2016, 17(7): 969-976. DOI: 10.1517/14656566.2016.1154539.
［10］ Reck M, Heigener D, Reinmuth N. Immunotherapy for smallcell lung cancer: emerging evidence［J］. Future Oncol, 2016, 12(7): 931-943. DOI: 10.2217/fon-2015-0012. |
